We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.16%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$44.5M
(+3.4%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
687
New
99
Increased
230
Reduced
280
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.2M |
| 2 |
Gilead Sciences
GILD
|
+$11.6M |
| 3 |
ConocoPhillips
COP
|
+$5.98M |
| 4 |
Morgan Stanley
MS
|
+$5.54M |
| 5 |
Capri Holdings
CPRI
|
+$3.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.9M |
| 2 |
American International
AIG
|
+$11.1M |
| 3 |
Texas Instruments
TXN
|
+$9.03M |
| 4 |
Prudential Financial
PRU
|
+$7.31M |
| 5 |
General Motors
GM
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.46% |
| 2 | Industrials | 14.03% |
| 3 | Technology | 11.99% |
| 4 | Healthcare | 11.73% |
| 5 | Consumer Staples | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Bankunited
BKU
$3.46B
| $452K | 0.03% |
14,952
+362
| +2% | +$11.1K |
|
502
Franklin Resources
BEN
$18.2B
| $451K | 0.03% |
12,690
+5,996
| +90% | +$212K |
|
|
AGTC
503
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $449K | 0.03% |
45,950
-318
| -0.7% | -$4.29K |
|
504
Hartford Financial Services
HIG
$38.9B
| $447K | 0.03% |
10,450
+2,812
| +37% | +$118K |
|
505
Extra Space Storage
EXR
$31.7B
| $441K | 0.03% |
5,559
-23,762
| -81% | -$2.01M |
|
|
ZLTQ
506
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $441K | 0.03% |
+11,250
| New | +$402K |
|
|
CEO
507
DELISTED
CNOOC Limited
CEO
| $439K | 0.03% |
3,472
-185
| -5% | -$22.7K |
|
508
Cabot Corp
CBT
$4.23B
| $432K | 0.03% |
8,236
+644
| +8% | +$31.9K |
|
|
TRCO
509
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $428K | 0.03% |
11,726
+2,294
| +24% | +$87K |
|
510
EQT Corp
EQT
$33B
| $421K | 0.03% |
+10,660
| New | +$421K |
|
|
SLCA
511
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $419K | 0.03% |
+8,990
| New | +$350K |
|
512
Cinemark Holdings
CNK
$4.41B
| $418K | 0.03% |
10,908
-2,320
| -18% | -$87.9K |
|
513
Federal Realty Investment Trust
FRT
$10.6B
| $416K | 0.03% |
2,704
-288
| -10% | -$46.6K |
|
514
Fortive
FTV
$18.3B
| $415K | 0.03% |
+12,933
| New | +$415K |
|
515
Sempra
SRE
$56.6B
| $412K | 0.03% |
+7,680
| New | +$418K |
|
|
AWH
516
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $401K | 0.03% |
9,915
-19,411
| -66% | -$767K |
|
517
John Wiley & Sons Class A
WLY
$2.78B
| $399K | 0.03% |
7,738
+1,130
| +17% | +$61.9K |
|
518
FirstEnergy
FE
$27.9B
| $394K | 0.03% |
11,908
+5,640
| +90% | +$192K |
|
519
GoDaddy
GDDY
$11.3B
| $393K | 0.03% |
11,390
-26,018
| -70% | -$830K |
|
|
VER
520
DELISTED
VEREIT, Inc.
VER
| $392K | 0.03% |
7,559
-2,036
| -21% | -$106K |
|
521
PG&E
PCG
$38.4B
| $391K | 0.03% |
+6,387
| New | +$406K |
|
522
Brinker International
EAT
$9.36B
| $385K | 0.03% |
7,638
-34,259
| -82% | -$1.72M |
|
523
Timken Company
TKR
$9.18B
| $384K | 0.03% |
10,938
-114,162
| -91% | -$3.76M |
|
|
TUP
524
DELISTED
Tupperware Brands Corporation
TUP
| $383K | 0.03% |
5,853
-624
| -10% | -$39.3K |
|
|
AIV
525
Aimco
AIV
$384M
| $382K | 0.03% |
62,434
-2,079
| -3% | -$12.5K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cadence Capital Management held 687 positions worth $1.37B, up 3.4% from $1.33B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Cadence Capital Management's Q3 2016 filing shows 99 new, 230 increased, 280 reduced and 72 closed positions. Its largest new stake was Bristol-Myers Squibb: 190,283 shares worth $10.3M. The largest sale was Apple, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
- Cadence Capital Management's largest Q3 2016 buy was Bristol-Myers Squibb: 190,283 shares worth $10.3M.
- Cadence Capital Management added most to Gilead Sciences in Q3 2016, an estimated $11.6M increase.
- Cadence Capital Management's biggest Q3 2016 reduction was Apple, cutting an estimated $11.9M.
- Cadence Capital Management fully exited American International in Q3 2016, selling an estimated $11.1M.
- Cadence Capital Management's ten largest holdings make up 10% of its $1.37B portfolio in Q3 2016.
- Cadence Capital Management opened 99 new positions and closed 72 in Q3 2016.
- Cadence Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.37B.
Based on Cadence Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.